MedTrace Logo

Percutaneous Localization: Open-label Registry of Thoracic Surgery

NCT04066699 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2024-05-17

No results posted yet for this study

Summary

The objectives of this study are to evaluate intraoperative percutaneous lung lesion marking assisted by electromagnetic guided percutaneous navigation and related tools.

Conditions

  • Lung Lesion(s) Requiring Evaluation
  • Pulmonary Metastasis
  • Pulmonary Nodule, Solitary
  • Peripheral Lung Lesions

Interventions

PROCEDURE

Percutaneous localization of suspicious lung lesion(s) using electromagnetic navigation and tools.

Transthoracic localization of suspicious lung lesion(s) in preparation for subsequent resection.

Sponsors & Collaborators

  • Veran Medical Technologies

    lead INDUSTRY

Principal Investigators

  • Faiz Bhora, MD · Hackensack Meridian Health Network & School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-10
Primary Completion
2023-01-05
Completion
2023-02-09
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04066699 on ClinicalTrials.gov